NASDAQ:NERV

Minerva Neurosciences Stock Predictions

etoro logo Buy NERV
*Your capital is at risk
$4.75
-0.0900 (-1.86%)
At Close: Jun 02, 2026
Currently predicting for Thu, 4 Jun 2026

NERV Prediction Chart

NERV Predictions History

Latest community submissions for NERV.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 16, 2022 $9.87 +8.96% $9.14 V 91.99% 1
JS JS Pro
Sep 16, 2022 $8.71 -3.86% $9.14 X 95.30% 0
Sep 16, 2022 Bullish $9.14 X 1
JS JS Pro
Sep 12, 2022 $10.03 -2.90% $9.82 X 97.86% 1
Sep 12, 2022 $15.00 +42.18% $9.82 X 47.25% 0
JS JS Pro
Sep 7, 2022 $8.66 -2.37% $9.35 V 92.62% 1
JS JS Pro
Oct 7, 2021 $1.37 -87.94% $1.42 V 96.48% 0
Rybkarybka Rybkarybka Merchant
Oct 7, 2021 $1.45 -87.24% $1.42 X 97.89% 1
JS JS Pro
Oct 5, 2021 $1.57 -86.47% $1.45 X 91.72% 0
Rybkarybka Rybkarybka Merchant
Oct 5, 2021 $1.67 -85.60% $1.45 X 84.83% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NERV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT MINERVA NEUROSCIENCES
Minerva Neurosciences
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE